MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Effect of Virtual Rehabilitation Therapy on Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis

    F. Luna-Rangel, B. Gonzalez-Bedolla, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To assess the efficacy of virtual rehabilitation therapy compared to conventional physical therapy in patients with Parkinson’s disease. Background: Rehabilitation is essential in managing…
  • 2025 International Congress

    Multimodal Dissection of GALC Variants Linking Olfactory Deficits to Cognitive Decline in Parkinson’s Disease

    Y. Li, M. Zhong, J. Liu (shanghai, China)

    Objective: Olfactory dysfunction is highly prevalent and often precedes motor symptoms, making it a potential early biomarker for disease progression and cognitive decline in Parkinson's…
  • 2025 International Congress

    Analysis of statistical data on patients with Parkinson’s disease.

    R. Matmurodov, S. Jumanazarova, E. Abduqodirov, M. Abdullayeva (Tashkent, Uzbekistan)

    Objective: To determine the spread of the disease by sex and age groups among the population of Uzbekistan. Background: Parkinson's disease is quite relevant throughout…
  • 2025 International Congress

    Study on individual differences in shoulder and hip joints during walking in patients with Parkinson’s disease

    J. Ogawa, Y. Yamaguchi, K. Kakegawa, T. Matsuda, T. Kurayama (Ginza, Chuo-ku, Japan)

    Objective: To analyze the motion characteristics of the shoulder and hip joints during gait in people with Parkinson’s disease (PwP) and explore the classification of…
  • 2025 International Congress

    The Role of Autophagy Lysosomal and Ubiquitin Proteasomal System in the Pathophysiology of Parkinson’s disease.

    B. Adebisi (Akure, Nigeria)

    Objective: The research how to better understand the molecular mechanism initiating the etiology of Parkinson's disease in order to appropriate the precise diagnosis and therapeutic…
  • 2025 International Congress

    Deferiprone improves striatal dopamine by reducing neuroinflammation and oxidative stress in MPTP-induced mice model of Parkinson’s disease

    HSA. Olasore, JO. Faleti (Lagos, Nigeria)

    Objective: This study aimed to investigate the effect of deferiprone on the striatal DA, oxidative stress and neuroinflammation markers as well as motor deficits in…
  • 2025 International Congress

    Profiling Neural Protein Dopaminylation in Parkinson’s disease

    W. Chen, I. Maze (NEW YORK, USA)

    Objective: The hallmark of Parkinson’s Disease is motor dysfunction from the decline in dopaminergic cells in the substantia nigra (SN), leading to the development of…
  • 2025 International Congress

    Metabolic Imaging Correlates of Apathy in Parkinson’s Disease.

    J. Arena, M. Ponce-de-Leon, L. Fiorentini, C. Obarrio, S. Vazquez, Y. Bergamo, M. Merello (Buenos Aires, Argentina)

    Objective: To investigate apathy-associated metabolic changes in Parkinson’s disease. Background: Apathy is a behavioral syndrome manifested as a decrease in goal-directed behaviors. It has been…
  • 2025 International Congress

    Bone Mineral Density in Early Parkinson’s Disease: Correlations with Disease Severity and Prognosis

    MG. Choi, SY. Jo, JY. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: This study aimed to evaluate the association between bone mineral density (BMD) and disease severity, progression, freezing of gait (FOG), and fracture risk in…
  • 2025 International Congress

    Evaluation of Perfusion, Iron Deposition, and Neuromelanin MRI Biomarkers Following Mesenchymal Stem Cell Treatment in a Phase 2 Parkinson’s Disease Trial

    J. Martinez-Lemus, E. Tharp, T. Ellmore, T. Thomas, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte-Rascon, R. Ritter Iii, M. Schiess (Houston, USA)

    Objective: Evaluate the effects of allogeneic bone marrow-derived mesenchymal stem cell (allo-hMSC) infusions on neuroimaging biomarkers in patients with Parkinson’s disease (PD) using different MRI…
  • « Previous Page
  • 1
  • …
  • 120
  • 121
  • 122
  • 123
  • 124
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley